If the price of crude oil softens, Indian equities may again see a risk-on phase. Tariff concerns are no longer the central issue; the larg...

Sakar Healthcare has partnered with Zydus Lifesciences to supply oncology products in GCC countries and other emerging markets. This marks ...

Bernstein has initiated coverage on six Indian pharma stocks, with Zydus Lifesciences as its top choice. The brokerage sees strong future g...

Global markets are under pressure due to rising bond yields and geopolitical tensions. Higher crude oil prices are a key concern, potential...

Global pharma major Bayer is significantly expanding its consumer healthcare presence in India, targeting the burgeoning self-care market e...

In the current phase of market volatility, the only solace to be derived is from market history. And history tells us that, just like good ...

Sun Pharma, led by Dilip Shanghvi, has agreed to acquire US-based Organon in an all-cash deal worth $11.75 billion, marking the largest acq...

Bain Capital has emerged as the frontrunner to acquire Vitabiotics, as rival bidders TPG Capital and EQT exit the process, potentially lowe...

Zydus Lifesciences Ltd. has appointed Swati Dalal as an additional director and Managing Director of its subsidiary, Zydus Healthcare Ltd.,...

Zydus Lifesciences reported that its subsidiary, Zydus Healthcare Ltd, has received an income tax notice demand of Rs 284.58 crore for the ...

The once-daily tablets are indicated as an adjunct to diet and exercise, and aim to improve glycemic control in adults with Type 2 diabetes...

The reason for recall is presence of foreign tablets. "Risperidone tablets were found in bottle of paroxetine tablets", the report said.

The acquired brands Deca-Durabolin, Durabolin, Sustanon, Multiload, Sicastat and Axeten range had clocked sales of Rs 840 million in 2015.

There will be no change in the shareholding pattern as business is transferred to a wholly owned subsidiary for cash consideration of Rs 69...

The company said these ANDAs have been acquired by its 100 per cent subsidiary, Zydus Worldwide DMCC and will be financed through the group...

Zydus Healthcare, a subsidiary of Cadila Healthcare, has acquired gastrointestinal brand 'Actibile' from drug firm Albert David for an undi...

In 2000, Zydus Cadila had created a strategic alliance with Ambalal Sarabhai Enterprises to integrate the animal healthcare business of bot...